Skip to main content
Erschienen in: Diabetologia 10/2006

01.10.2006 | Article

BCL-6: a possible missing link for anti-inflammatory PPAR-δ signalling in pancreatic beta cells

verfasst von: I. Kharroubi, C.-H. Lee, P. Hekerman, M. I. Darville, R. M. Evans, D. L. Eizirik, M. Cnop

Erschienen in: Diabetologia | Ausgabe 10/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Inflammatory mediators contribute to pancreatic beta cell death in type 1 diabetes. Beta cells respond to cytokine exposure by activating gene networks that alter cellular metabolism, induce chemokine release (thereby increasing insulitis), and cause apoptosis. We have previously shown by microarray analysis that exposure of INS-1E cells to IL-1β + IFN-γ induces the transcription factor peroxisome proliferator-activated receptor (Ppar)-δ and several of its target genes. PPAR-δ controls cellular lipid metabolism and is a major regulator of inflammatory responses. We therefore examined the role of PPAR-δ in cytokine-treated beta cells.

Materials and methods

Primary beta cells that had been purified by fluorescence-activated cell sorting and INS-1E cells were cultured in the presence of the cytokines TNF-α, IL-1β, or IL-1β + IFN-γ, or the synthetic PPAR-δ agonist GW501516. Gene expression was analysed by real-time PCR. PPAR-δ, monocyte chemoattractant protein (MCP-1, now known as CCL2) promoter and NF-κB activity were determined by luciferase reporter assays.

Results

Exposure of primary beta cells or INS-1E cells to cytokines induced Ppar-δ mRNA expression and PPAR-δ-dependent CD36, lipoprotein lipase, acyl CoA synthetase and adipophilin mRNAs. Cytokines and the PPAR-δ agonist GW501516 also activated a PPAR-δ response element reporter in beta cells. Unlike immune cells, neither INS-1E nor beta cells expressed the transcriptional repressor B-cell lymphoma-6 (BCL-6). As a consequence, PPAR-δ activation by GW501516 did not decrease cytokine-induced Mcp-1 promoter activation or mRNA expression, as reported for macrophages. Transient transfection with a BCL-6 expression vector markedly reduced Mcp-1 promoter and NF-κB activities in beta cells.

Conclusions/interpretation

Cytokines activate the PPAR-δ gene network in beta cells. This network does not, however, regulate the pro-inflammatory response to cytokines because beta cells lack constitutive BCL-6 expression. This may render beta cells particularly susceptible to propagating inflammation in type 1 diabetes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Eizirik DL, Mandrup-Poulsen T (2001) A choice of death—the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 44:2115–2133PubMedCrossRef Eizirik DL, Mandrup-Poulsen T (2001) A choice of death—the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 44:2115–2133PubMedCrossRef
2.
Zurück zum Zitat Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97–S107PubMedCrossRef Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97–S107PubMedCrossRef
3.
Zurück zum Zitat Cardozo AK, Heimberg H, Heremans Y et al (2001) A comprehensive analysis of cytokine-induced and nuclear factor-κB-dependent genes in primary rat pancreatic β-cells. J Biol Chem 276:48879–48886PubMedCrossRef Cardozo AK, Heimberg H, Heremans Y et al (2001) A comprehensive analysis of cytokine-induced and nuclear factor-κB-dependent genes in primary rat pancreatic β-cells. J Biol Chem 276:48879–48886PubMedCrossRef
4.
Zurück zum Zitat Eldor R, Yeffet A, Baum K et al (2006) Conditional and specific NF-κB blockade protects pancreatic beta cells from diabetogenic agents. Proc Natl Acad Sci USA 103:5072–5077PubMedCrossRef Eldor R, Yeffet A, Baum K et al (2006) Conditional and specific NF-κB blockade protects pancreatic beta cells from diabetogenic agents. Proc Natl Acad Sci USA 103:5072–5077PubMedCrossRef
5.
Zurück zum Zitat Heimberg H, Heremans Y, Jobin C et al (2001) Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis. Diabetes 50:2219–2224PubMedCrossRef Heimberg H, Heremans Y, Jobin C et al (2001) Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis. Diabetes 50:2219–2224PubMedCrossRef
6.
Zurück zum Zitat Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL (2003) IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46:255–266PubMed Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL (2003) IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46:255–266PubMed
7.
Zurück zum Zitat Kutlu B, Cardozo AK, Darville MI et al (2003) Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 52:2701–2719PubMedCrossRef Kutlu B, Cardozo AK, Darville MI et al (2003) Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 52:2701–2719PubMedCrossRef
8.
Zurück zum Zitat Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998) The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391:79–82PubMedCrossRef Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998) The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391:79–82PubMedCrossRef
9.
Zurück zum Zitat Peters JM, Lee SS, Li W et al (2000) Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β(δ). Mol Cell Biol 20:5119–5128PubMedCrossRef Peters JM, Lee SS, Li W et al (2000) Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β(δ). Mol Cell Biol 20:5119–5128PubMedCrossRef
10.
Zurück zum Zitat Vosper H, Patel L, Graham TL et al (2001) The peroxisome proliferator-activated receptor δ promotes lipid accumulation in human macrophages. J Biol Chem 276:44258–44265PubMedCrossRef Vosper H, Patel L, Graham TL et al (2001) The peroxisome proliferator-activated receptor δ promotes lipid accumulation in human macrophages. J Biol Chem 276:44258–44265PubMedCrossRef
11.
Zurück zum Zitat Oliver WR Jr, Shenk JL, Snaith MR et al (2001) A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 98:5306–5311PubMedCrossRef Oliver WR Jr, Shenk JL, Snaith MR et al (2001) A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 98:5306–5311PubMedCrossRef
12.
Zurück zum Zitat Cheng L, Ding G, Qin Q et al (2004) Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10:1245–1250PubMedCrossRef Cheng L, Ding G, Qin Q et al (2004) Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10:1245–1250PubMedCrossRef
13.
Zurück zum Zitat Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P, Muscat GE (2003) The peroxisome proliferator-activated receptor β/δ agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol 17:2477–2493PubMedCrossRef Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P, Muscat GE (2003) The peroxisome proliferator-activated receptor β/δ agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol 17:2477–2493PubMedCrossRef
14.
Zurück zum Zitat Tanaka T, Yamamoto J, Iwasaki S et al (2003) Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA 100:15924–15929PubMedCrossRef Tanaka T, Yamamoto J, Iwasaki S et al (2003) Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA 100:15924–15929PubMedCrossRef
15.
Zurück zum Zitat Lee CH, Olson P, Hevener A et al (2006) PPARδ regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci USA 103:3444–3449PubMedCrossRef Lee CH, Olson P, Hevener A et al (2006) PPARδ regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci USA 103:3444–3449PubMedCrossRef
16.
Zurück zum Zitat Lee CH, Chawla A, Urbiztondo N, Liao D, Boisvert WA, Evans RM (2003) Transcriptional repression of atherogenic inflammation: modulation by PPARδ. Science 302:453–457PubMedCrossRef Lee CH, Chawla A, Urbiztondo N, Liao D, Boisvert WA, Evans RM (2003) Transcriptional repression of atherogenic inflammation: modulation by PPARδ. Science 302:453–457PubMedCrossRef
17.
Zurück zum Zitat Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 137:354–366PubMedCrossRef Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 137:354–366PubMedCrossRef
18.
Zurück zum Zitat Rasschaert J, Ladriere L, Urbain M et al (2005) Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA + interferon-γ-induced apoptosis in primary pancreatic β-cells. J Biol Chem 280:33984–33991PubMedCrossRef Rasschaert J, Ladriere L, Urbain M et al (2005) Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA + interferon-γ-induced apoptosis in primary pancreatic β-cells. J Biol Chem 280:33984–33991PubMedCrossRef
19.
Zurück zum Zitat Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB (1992) Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130:167–178PubMedCrossRef Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB (1992) Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130:167–178PubMedCrossRef
20.
Zurück zum Zitat Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL (2001) Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1β-exposed human and rat islet cells. Diabetologia 44:325–332PubMedCrossRef Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL (2001) Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1β-exposed human and rat islet cells. Diabetologia 44:325–332PubMedCrossRef
21.
Zurück zum Zitat Kharroubi I, Rasschaert J, Eizirik DL, Cnop M (2003) Expression of adiponectin receptors in pancreatic β cells. Biochem Biophys Res Commun 312:1118–1122PubMedCrossRef Kharroubi I, Rasschaert J, Eizirik DL, Cnop M (2003) Expression of adiponectin receptors in pancreatic β cells. Biochem Biophys Res Commun 312:1118–1122PubMedCrossRef
22.
Zurück zum Zitat Overbergh L, Valckx D, Waer M, Mathieu C (1999) Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305–312PubMedCrossRef Overbergh L, Valckx D, Waer M, Mathieu C (1999) Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305–312PubMedCrossRef
23.
Zurück zum Zitat Chen MC, Schuit F, Eizirik DL (1999) Identification of IL-1β-induced messenger RNAs in rat pancreatic beta cells by differential display of messenger RNA. Diabetologia 42:1199–1203PubMedCrossRef Chen MC, Schuit F, Eizirik DL (1999) Identification of IL-1β-induced messenger RNAs in rat pancreatic beta cells by differential display of messenger RNA. Diabetologia 42:1199–1203PubMedCrossRef
24.
Zurück zum Zitat Chawla A, Lee CH, Barak Y et al (2003) PPARδ is a very low-density lipoprotein sensor in macrophages. Proc Natl Acad Sci USA 100:1268–1273PubMedCrossRef Chawla A, Lee CH, Barak Y et al (2003) PPARδ is a very low-density lipoprotein sensor in macrophages. Proc Natl Acad Sci USA 100:1268–1273PubMedCrossRef
25.
Zurück zum Zitat Kutlu B, Darville MI, Cardozo AK, Eizirik DL (2003) Molecular regulation of monocyte chemoattractant protein-1 expression in pancreatic β-cells. Diabetes 52:348–355PubMedCrossRef Kutlu B, Darville MI, Cardozo AK, Eizirik DL (2003) Molecular regulation of monocyte chemoattractant protein-1 expression in pancreatic β-cells. Diabetes 52:348–355PubMedCrossRef
26.
Zurück zum Zitat Darville MI, Eizirik DL (1998) Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 41:1101–1108PubMedCrossRef Darville MI, Eizirik DL (1998) Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 41:1101–1108PubMedCrossRef
27.
Zurück zum Zitat Eizirik DL (1991) Interleukin-1β induces an early decrease in insulin release, (pro)insulin biosynthesis and insulin mRNA in mouse pancreatic islets by a mechanism dependent on gene transcription and protein synthesis. Autoimmunity 10:107–113PubMed Eizirik DL (1991) Interleukin-1β induces an early decrease in insulin release, (pro)insulin biosynthesis and insulin mRNA in mouse pancreatic islets by a mechanism dependent on gene transcription and protein synthesis. Autoimmunity 10:107–113PubMed
28.
Zurück zum Zitat Hoorens A, Van de Casteele M, Kloppel G, Pipeleers D (1996) Glucose promotes survival of rat pancreatic β cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 98:1568–1574PubMedCrossRef Hoorens A, Van de Casteele M, Kloppel G, Pipeleers D (1996) Glucose promotes survival of rat pancreatic β cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 98:1568–1574PubMedCrossRef
29.
Zurück zum Zitat Gremlich S, Nolan C, Roduit R et al (2005) Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor α transcriptional up-regulation of fatty acid oxidation. Endocrinology 146:375–382PubMedCrossRef Gremlich S, Nolan C, Roduit R et al (2005) Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor α transcriptional up-regulation of fatty acid oxidation. Endocrinology 146:375–382PubMedCrossRef
30.
Zurück zum Zitat Ito E, Ozawa S, Takahashi K et al (2004) PPAR-γ overexpression selectively suppresses insulin secretory capacity in isolated pancreatic islets through induction of UCP-2 protein. Biochem Biophys Res Commun 324:810–814PubMedCrossRef Ito E, Ozawa S, Takahashi K et al (2004) PPAR-γ overexpression selectively suppresses insulin secretory capacity in isolated pancreatic islets through induction of UCP-2 protein. Biochem Biophys Res Commun 324:810–814PubMedCrossRef
31.
Zurück zum Zitat Parton LE, Diraison F, Neill SE et al (2004) Impact of PPARγ overexpression and activation on pancreatic islet gene expression profile analyzed with oligonucleotide microarrays. Am J Physiol Endocrinol Metab 287:E390–E404PubMedCrossRef Parton LE, Diraison F, Neill SE et al (2004) Impact of PPARγ overexpression and activation on pancreatic islet gene expression profile analyzed with oligonucleotide microarrays. Am J Physiol Endocrinol Metab 287:E390–E404PubMedCrossRef
32.
Zurück zum Zitat Dent AL, Vasanwala FH, Toney LM (2002) Regulation of gene expression by the proto-oncogene BCL-6. Crit Rev Oncol Hematol 41:1–9PubMed Dent AL, Vasanwala FH, Toney LM (2002) Regulation of gene expression by the proto-oncogene BCL-6. Crit Rev Oncol Hematol 41:1–9PubMed
33.
Zurück zum Zitat Li Z, Wang X, Yu RY et al (2005) BCL-6 negatively regulates expression of the NF-κB1 p105/p50 subunit. J Immunol 174:205–214PubMed Li Z, Wang X, Yu RY et al (2005) BCL-6 negatively regulates expression of the NF-κB1 p105/p50 subunit. J Immunol 174:205–214PubMed
34.
Zurück zum Zitat Planavila A, Laguna JC, Vazquez-Carrera M (2005) Nuclear factor-κB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy. J Biol Chem 280:17464–17471PubMedCrossRef Planavila A, Laguna JC, Vazquez-Carrera M (2005) Nuclear factor-κB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy. J Biol Chem 280:17464–17471PubMedCrossRef
35.
Zurück zum Zitat Berry EB, Keelan JA, Helliwell RJ, Gilmour RS, Mitchell MD (2005) Nanomolar and micromolar effects of 15-deoxy-δ12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors γ and δ and nuclear factor κB. Mol Pharmacol 68:169–178PubMed Berry EB, Keelan JA, Helliwell RJ, Gilmour RS, Mitchell MD (2005) Nanomolar and micromolar effects of 15-deoxy-δ12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors γ and δ and nuclear factor κB. Mol Pharmacol 68:169–178PubMed
36.
Zurück zum Zitat Tous M, Ferre N, Rull A et al (2006) Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochem Biophys Res Commun 340:1078–1084PubMedCrossRef Tous M, Ferre N, Rull A et al (2006) Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochem Biophys Res Commun 340:1078–1084PubMedCrossRef
Metadaten
Titel
BCL-6: a possible missing link for anti-inflammatory PPAR-δ signalling in pancreatic beta cells
verfasst von
I. Kharroubi
C.-H. Lee
P. Hekerman
M. I. Darville
R. M. Evans
D. L. Eizirik
M. Cnop
Publikationsdatum
01.10.2006
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 10/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0366-5

Weitere Artikel der Ausgabe 10/2006

Diabetologia 10/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.